This inventor holds 1 USPTO granted patent. Top assignee: China Pharmaceutical University. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations in Pulmonary Fibrosis Treatment by Juan Xiang
Introduction
Juan Xiang is an accomplished inventor based in Jiangsu, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pulmonary fibrosis. His innovative approach focuses on the use of alkaloids in developing effective medications.
Latest Patents
Juan Xiang holds a patent for the "Use of alkaloid in preparing pharmaceutical compositions for preventing or treating pulmonary fibrosis." This patent describes a new application of a compound that effectively reduces inflammation in diseased lung tissue. It also lowers the concentration of fibrosis factors TGF-βI and decreases excessive collagen deposition, demonstrating substantial effectiveness in preventing and treating fibrosis.
Career Highlights
Juan Xiang is affiliated with China Pharmaceutical University, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on patients suffering from pulmonary fibrosis.
Collaborations
Juan collaborates with notable colleagues, including Yan Wu and Mian Zhang, who contribute to his research endeavors.
Conclusion
Juan Xiang's innovative work in the pharmaceutical field highlights the importance of research in developing effective treatments for pulmonary fibrosis. His contributions are paving the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile